Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8082397 | 0.99 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL8082404 | 0.99 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL4985086 | 0.96 | CASP3 (0.46) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL4985094 | 0.96 | CASP3 (0.46) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL10795974 | 0.95 | CASP3 (0.46) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL10795978 | 0.95 | CASP3 (0.46) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL10915168 | 0.95 | CASP3 (0.46) | SMN1; SMN2CYP2C19CASP3FKBP1AACE | |
| SCHEMBL10896117 | 0.95 | CASP3 (0.46) | SMN1; SMN2CYP2C19CASP3FKBP1AACE | |
| SCHEMBL17949283 | 0.92 | SMN1; SMN2 (0.46) | SMN1; SMN2CYP2C19ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL15368459 | 0.85 | PER2 (0.45) | SMN1; SMN2ALDH1A1MAPK1L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197869-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-06-19 | — | — | US | disclosed |
| US-12264318-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-04-01 | — | — | US | disclosed |
| US-20230046194-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-02-16 | — | — | US | disclosed |
| US-11434492-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2022-09-06 | — | — | US | disclosed |
| US-20180002709-A1 | RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-01-04 | — | — | US | disclosed |
| WO-2016118877-A1 | RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS | ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-07-28 | — | — | WO | disclosed |
| US-6034215-A | 3-amino-2-oxo-1-piperidnercetic derivatives as enzyme inhibitors | CORVAS INTERNATIONAL, INC. (US) | 2000-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002709-A1 | RIBOSOME-MEDIATED INCORPORATION OF PEPTIDES AND PEPTIDOMIMETICS | NPEPPS, DNPEP, AARS1 | SMN1; SMN2 2495/4885CYP2C19 4615/4885ALDH1A1 4835/4885 |
| US-20230046194-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | NPEPPS, DNPEP, AARS1 | SMN1; SMN2 2495/4885CYP2C19 4615/4885ALDH1A1 4835/4885 |
| US-12264318-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | NPEPPS, DNPEP, AARS1 | SMN1; SMN2 2495/4885CYP2C19 4615/4885ALDH1A1 4835/4885 |
| US-20250197869-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | NPEPPS, DNPEP, AARS1 | SMN1; SMN2 2495/4885CYP2C19 4615/4885ALDH1A1 4835/4885 |
| US-11434492-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | NPEPPS, DNPEP, AARS1 | SMN1; SMN2 2495/4885CYP2C19 4615/4885ALDH1A1 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.